Drug General Information
Drug ID D0DP0J
Drug Name PR-924
Structure D0DP0J
Drug Resistance Mutations
Target Name Proteasome subunit beta type-5 (PSMB5) Target Info
Gene Name PSMB5
Uniprot ID PSB5_HUMAN
Species Homo sapiens
Reference Sequence MALASVLERPLPVNQRGFFGLGGRADLLDLGPGSLSDGLSLAAPGWGVPEEPGIEMLHGT
TTLAFKFRHGVIVAADSRATAGAYIASQTVKKVIEINPYLLGTMAGGAADCSFWERLLAR
QCRIYELRNKERISVAAASKLLANMVYQYKGMGLSMGTMICGWDKRGPGLYYVDSEGNRI
SGATFSVGSGSVYAYGVMDRGYSYDLEVEQAYDLARRAIYQATYRDAYSGGAVNLYHVRE
DGWIRVSSDNVADLHEKYSGSTP [Homo sapiens]
Targeted Disease Leukemia
Drug Resistance Mutations
Mutation info Missense: A49T [1]
Level of Resistance Confer 13 fold resistance
Mutation info Missense: M45I [1]
Level of Resistance Confer 13 fold resistance
Mutation info Missense: M45V [1]
Level of Resistance Confer 13 fold resistance
References
REF 1 Anti-leukemic activity and mechanisms underlying resistance to the novel immunoproteasome inhibitor PR-924.Biochem Pharmacol.2014 May 1;89(1):43-51.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.